BX Swiss TOP 30 CHF
1.228,04
PKT
-12,73
PKT
-1,03
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.02.18 | Roche Neutral | UBS AG | |
| 06.02.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.02.18 | Roche overweight | JP Morgan Chase & Co. | |
| 06.02.18 | Givaudan Neutral | UBS AG | |
| 05.02.18 | Roche overweight | Barclays Capital | |
| 05.02.18 | Givaudan Neutral | UBS AG | |
| 05.02.18 | Roche Hold | Deutsche Bank AG | |
| 02.02.18 | Roche overweight | JP Morgan Chase & Co. | |
| 02.02.18 | Roche kaufen | DZ BANK | |
| 02.02.18 | Roche Outperform | Bernstein Research | |
| 02.02.18 | Swiss Re buy | Deutsche Bank AG | |
| 01.02.18 | Zurich Insurance Equal weight | Barclays Capital | |
| 01.02.18 | Swiss Re overweight | Barclays Capital | |
| 01.02.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 31.01.18 | Nestlé Neutral | BNP PARIBAS | |
| 30.01.18 | Givaudan Sell | Citigroup Corp. | |
| 30.01.18 | Givaudan Hold | Deutsche Bank AG | |
| 29.01.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 29.01.18 | Givaudan overweight | JP Morgan Chase & Co. | |
| 29.01.18 | Givaudan Hold | Kepler Cheuvreux | |
| 29.01.18 | Givaudan Underweight | Barclays Capital | |
| 29.01.18 | UBS overweight | Morgan Stanley | |
| 29.01.18 | Givaudan Underperform | Bernstein Research | |
| 29.01.18 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 29.01.18 | Holcim verkaufen | Barclays Capital | |
| 26.01.18 | Zurich Insurance Outperform | Credit Suisse Group | |
| 26.01.18 | Nestlé overweight | JP Morgan Chase & Co. | |
| 26.01.18 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.01.18 | UBS Sector Perform | RBC Capital Markets | |
| 26.01.18 | Holcim Underperform | BNP PARIBAS | |
| 26.01.18 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 26.01.18 | Givaudan overweight | JP Morgan Chase & Co. | |
| 25.01.18 | Holcim Underperform | BNP PARIBAS | |
| 25.01.18 | Novartis overweight | Morgan Stanley | |
| 25.01.18 | Novartis Hold | Deutsche Bank AG | |
| 25.01.18 | Novartis Hold | S&P Capital IQ | |
| 25.01.18 | ABB (Asea Brown Boveri) Hold | Baader Bank | |
| 25.01.18 | Novartis Underweight | Barclays Capital | |
| 25.01.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 24.01.18 | Novartis Neutral | Credit Suisse Group |